The urgency of resuming disrupted dog rabies vaccination campaigns: a modeling and cost-effectiveness analysis
View ORCID ProfileAmber Kunkel, View ORCID ProfileSeonghye Jeon, View ORCID ProfileHaim C Joseph, View ORCID ProfilePierre Dilius, View ORCID ProfileKelly Crowdis, View ORCID ProfileMartin I. Meltzer, Ryan Wallace
doi: https://doi.org/10.1101/2021.04.24.21256032
Amber Kunkel
1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
2Epidemic Intelligence Service, Center for Surveillance, Epidemiology and Laboratory Services, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Seonghye Jeon
3Emergency Preparedness and Response Branch, Division of Preparedness and Emerging Infections, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Haim C Joseph
4Ministry of Agriculture, Rural Development, and Natural Resources, Port-au-Prince, Haiti
Pierre Dilius
4Ministry of Agriculture, Rural Development, and Natural Resources, Port-au-Prince, Haiti
Kelly Crowdis
5Christian Veterinary Mission, Port-au-Prince, Haiti
Martin I. Meltzer
3Emergency Preparedness and Response Branch, Division of Preparedness and Emerging Infections, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
Ryan Wallace
1Poxvirus and Rabies Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging & Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted April 26, 2021.
The urgency of resuming disrupted dog rabies vaccination campaigns: a modeling and cost-effectiveness analysis
Amber Kunkel, Seonghye Jeon, Haim C Joseph, Pierre Dilius, Kelly Crowdis, Martin I. Meltzer, Ryan Wallace
medRxiv 2021.04.24.21256032; doi: https://doi.org/10.1101/2021.04.24.21256032
Subject Area
Subject Areas
- Addiction Medicine (336)
- Allergy and Immunology (664)
- Anesthesia (178)
- Cardiovascular Medicine (2600)
- Dermatology (218)
- Emergency Medicine (391)
- Epidemiology (12139)
- Forensic Medicine (10)
- Gastroenterology (752)
- Genetic and Genomic Medicine (4035)
- Geriatric Medicine (380)
- Health Economics (671)
- Health Informatics (2607)
- Health Policy (995)
- Hematology (359)
- HIV/AIDS (833)
- Medical Education (397)
- Medical Ethics (109)
- Nephrology (426)
- Neurology (3804)
- Nursing (208)
- Nutrition (567)
- Oncology (1991)
- Ophthalmology (578)
- Orthopedics (235)
- Otolaryngology (303)
- Pain Medicine (250)
- Palliative Medicine (73)
- Pathology (470)
- Pediatrics (1100)
- Primary Care Research (443)
- Public and Global Health (6473)
- Radiology and Imaging (1379)
- Respiratory Medicine (866)
- Rheumatology (395)
- Sports Medicine (337)
- Surgery (438)
- Toxicology (52)
- Transplantation (185)
- Urology (165)